VERU
VERU INC.Company Information
- Company Name
- VERU INC.
- CIK
- CIK0000863894
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- VERU: Nasdaq
- Fiscal Year End
- September 30
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- VERU
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-08-13
- Last sale
- 2024-05-24
- Shares purchased (TTM)
- 1,800
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 2,745,083
- Shares outstanding
- 23,050,320
- Ownership
- 11.91%
Earnings Market Reaction
- Filing date
- 2026-08-10
- Price on filing date
- —
- 1-month reaction
- -4.69%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | - | - | - | - | - | - | - | - | - | 35 | 41 | 10 | ||||||
| Cash And Cash Equivalents At Carrying Value | 24 | 28 | 33 | 16 | 15 | 20 | 27 | 25 | 29 | - | - | 10 | ||||||
| Equity Securities Fv Ni | 2 | 3 | 2 | 3 | - | - | - | 1 | - | - | - | - | ||||||
| Accounts Receivable Net Current | - | - | - | - | - | - | - | 4 | 2 | 3 | 2 | 5 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 3 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 2 | 1 | ||||||
| Inventory Net | - | - | - | - | - | - | - | 4 | 5 | 5 | 7 | 7 | ||||||
| Assets Of Disposal Group Including Discontinued Operation Current | - | - | - | 0 | 0 | 0 | 0 | 9 | - | - | - | - | ||||||
| Assets Current | 27 | 33 | 37 | 19 | 16 | 21 | 28 | 35 | 38 | 45 | 53 | 23 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 2 | ||||||
| Operating Lease Right Of Use Asset | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | ||||||
| Equity Securities F V N I Noncurrent | - | - | - | - | - | - | - | - | 0 | 0 | 1 | - | ||||||
| Goodwill | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | ||||||
| Other Assets Noncurrent | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | ||||||
| Deferred Income Tax Assets Net | - | - | - | - | - | - | - | 12 | 12 | 13 | 13 | 13 | ||||||
| Disposal Group Including Discontinued Operation Assets Noncurrent | - | - | - | 0 | 0 | 0 | 0 | 14 | - | - | - | - | ||||||
| Intangible Assets Net Excluding Goodwill | - | - | - | - | - | - | - | 0 | - | - | - | 0 | ||||||
| Assets | 37 | 43 | 48 | 30 | 27 | 33 | 40 | 60 | 65 | 72 | 81 | 50 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 2 | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 3 | 2 | 11 | 13 | ||||||
| Deferred Compensation Liability Current | - | - | - | - | - | - | - | - | - | 3 | 2 | 1 | ||||||
| Employee Related Liabilities Current | 3 | 2 | 5 | 4 | 3 | 2 | 2 | 4 | 3 | - | - | 1 | ||||||
| Accounts Payable And Other Accrued Liabilities Current | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 2 | 2 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | - | - | - | 0 | 0 | 0 | 0 | 3 | - | - | - | - | ||||||
| Liabilities Current | 6 | 5 | 7 | 8 | 7 | 6 | 6 | 12 | 11 | 10 | 17 | 18 | ||||||
| Operating Lease Liability Noncurrent | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | ||||||
| Other Liabilities Noncurrent | 1 | 1 | 1 | 1 | 3 | 3 | 4 | 4 | 5 | 5 | - | 0 | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Noncurrent | - | - | - | 0 | 0 | 0 | 0 | 0 | - | - | - | - | ||||||
| Liabilities | 9 | 8 | 10 | 12 | 12 | 12 | 13 | 28 | 27 | 27 | 29 | 30 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | ||||||
| Additional Paid In Capital | 368 | 368 | 367 | 343 | 342 | 339 | 336 | 335 | 331 | 327 | 324 | 284 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -1 | -1 | -1 | ||||||
| Retained Earnings Accumulated Deficit | -332 | -325 | -323 | -317 | -319 | -311 | -304 | -295 | -286 | -275 | -265 | -257 | ||||||
| Treasury Stock Common Value | -8 | -8 | -8 | -8 | -8 | -8 | -8 | -8 | -8 | -8 | -8 | -8 | ||||||
| Stockholders Equity | 28 | 35 | 37 | 18 | 15 | 21 | 27 | 32 | 38 | 45 | 52 | 20 | ||||||
| Liabilities And Stockholders Equity | 37 | 43 | 48 | 30 | 27 | 33 | 40 | 60 | 65 | 72 | 81 | 50 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 308 | 308 | 308 | 308 | 308 | 308 | 308 | 308 | 308 | 308 | 308 | 308 | ||||||
| Common Stock Shares Issued | 17 | 16 | 16 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 9 | ||||||
| Shares Outstanding | 17 | 16 | 16 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 9 | ||||||
| Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 2 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialVERU INC. (VERU) — SEC Financial Statements & Analysis
VERU INC. (VERU) is a pharmaceutical preparations company, incorporated in WI. VERU INC. trades on Nasdaq as: VERU. VERU INC. (VERU)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10. Based on that filing, VERU INC. carries a market cap of $72.15M, a P/E ratio of -5.30x, a P/B ratio of 2.54x, a P/S ratio of 12.77x, an enterprise value of $48.27M, and an EV/EBITDA multiple of -2.53x. On profitability, it posts a gross margin of 34.67%, an operating margin of -529.71%, a net margin of -491.40%, a Return on Equity (ROE) of -62.25%, a Return on Assets (ROA) of -42.29%, and a Return on Invested Capital (ROIC) of -773.21%. Per share, it reports EPS of $-0.59, diluted EPS of $-2.66, free cash flow per share of $-1.13, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of -58.40% year-over-year, and EPS growth of -73.54% year-over-year. On the balance sheet, it maintains a current ratio of 4.42x, a quick ratio of 4.19x, working capital of $21.07M, a debt-to-equity ratio of 0.30x, a debt ratio of 0.23, an interest coverage ratio of -73.44x, free cash flow of $-26.04M (TTM), and net debt of $-23.88M. Figures sourced from SEC EDGAR.
- Market Cap
- $72.15M
- P/E TTM
- -5.30x
- EPS TTM
- $-0.59
- P/B TTM
- 2.54x
- ROE TTM
- -62.25%
- ROA TTM
- -42.29%
- Debt To Equity
- 0.30x
- Free Cash Flow TTM
- $-26.04M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is VERU INC. in?
VERU INC. (VERU) operates in the Pharmaceutical Preparations industry.
What exchange does VERU trade on?
VERU INC. (VERU) trades on the Nasdaq.
Where is VERU INC. incorporated?
VERU INC. is incorporated in WI.
When was VERU INC. (VERU)'s most recent SEC filing?
VERU INC. (VERU)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10.
What is VERU's market cap?
VERU INC. (VERU) has a market capitalization of $72.15M as of 2026-06-30.
What is VERU's EPS (earnings per share)?
VERU INC. (VERU)'s trailing twelve month EPS is $-0.59 as of 2026-06-30.
What is VERU's ROE (return on equity)?
VERU INC. (VERU)'s trailing twelve month Return on Equity (ROE) is -62.25% as of 2026-06-30.
What is VERU's ROA (return on assets)?
VERU INC. (VERU)'s trailing twelve month Return on Assets (ROA) is -42.29% as of 2026-06-30.
What is VERU's ROIC (return on invested capital)?
VERU INC. (VERU)'s trailing twelve month Return on Invested Capital (ROIC) is -773.21% as of 2026-06-30.
What is VERU's EV/EBITDA?
VERU INC. (VERU)'s trailing twelve month EV/EBITDA is -2.53x as of 2026-06-30.